```html

Kidney Failure (Acute Renal Failure) – A Practical Medical Guide

Overview

Acute renal failure (ARF), more commonly called acute kidney injury (AKI), is a sudden decline in kidney function that develops over hours to days. The kidneys lose the ability to filter waste products, balance electrolytes, and regulate fluid volume. If untreated, AKI can progress to chronic kidney disease (CKD) or become life‑threatening.

AKI can affect people of any age, but certain groups are more vulnerable:

• Hospitalized patients, especially those in intensive‑care units (ICUs)
• Elderly individuals (≥65 years) due to decreased renal reserve
• People with pre‑existing kidney disease, heart failure, liver disease, or diabetes

According to the CDC, roughly 1 in 5 hospitalized adults develop AKI, and incidence rises to ~30 % among ICU patients. In the United States, AKI accounts for an estimated 300,000–500,000 hospital admissions each year, with a mortality rate of 10–30 % depending on severity and comorbidities (Mayo Clinic).

Symptoms

Symptoms may appear rapidly and can be subtle early on. The classic “oliguria” (low urine output) is not always present; up to 40 % of patients maintain normal urine volume despite severe injury.

General Symptoms

• Decreased urine output (oliguria < 400 mL/24 h) or, less commonly, complete absence of urine (anuria).
• Fluid retention – swelling (edema) in legs, ankles, or around the eyes.
• Shortness of breath – due to fluid accumulation in the lungs (pulmonary edema).
• Fatigue, weakness, confusion – resulting from electrolyte imbalances and toxin buildup.
• Nausea, vomiting, loss of appetite – gastrointestinal upset is common.

Laboratory‑Based Signs (Detected by Tests)

• Rise in serum creatinine by ≥0.3 mg/dL within 48 h, or a 1.5‑fold increase from baseline within 7 days (KDIGO criteria).
• Elevated blood urea nitrogen (BUN).
• Electrolyte disturbances: hyperkalemia, metabolic acidosis, hyponatremia.
• Abnormal urine findings – protein, blood, casts.

Causes and Risk Factors

AKI is typically classified into three mechanistic categories:

1. Prerenal (Decreased Blood Flow to the Kidneys)

• Severe dehydration (vomiting, diarrhea, burns)
• Hypotension from heart failure, sepsis, or major bleeding
• Medications that impair renal perfusion (e.g., ACE inhibitors, ARBs, NSAIDs) in volume‑depleted patients

2. Intrinsic (Direct Damage to Kidney Tissue)

• Acute tubular necrosis (ATN) – most common; caused by prolonged ischemia or nephrotoxic drugs (aminoglycosides, contrast dye, amphotericin B).
• Glomerulonephritis – autoimmune or infection‑related inflammation.
• Acute interstitial nephritis – allergic reaction to drugs (penicillins, PPIs, NSAIDs).
• Vascular events – renal artery thrombosis, emboli.

3. Post‑renal (Obstruction of Urine Flow)

• Ureteral stones, bladder outlet obstruction (BPH, prostate cancer)
• Neurogenic bladder, severe pelvic tumors.

Risk Factors

• Age > 65 years
• Existing CKD (eGFR < 60 mL/min/1.73 m²)
• Diabetes mellitus or uncontrolled hypertension
• Heart failure, liver cirrhosis, or severe sepsis
• Exposure to nephrotoxic agents (contrast media, certain antibiotics, chemotherapy)
• Major surgery, especially cardiac or vascular procedures

Diagnosis

Timely diagnosis hinges on clinical suspicion, laboratory data, and imaging.

Initial Laboratory Assessment

• Serum creatinine & BUN – track rise over time.
• Electrolytes – potassium, bicarbonate, sodium.
• Complete blood count – detect anemia, infection.
• Urinalysis – look for protein, hematuria, casts (e.g., granular or epithelial casts suggest ATN).

Imaging

• Renal ultrasound – first‑line to rule out obstruction; assesses kidney size and echogenicity.
• CT scan with contrast is generally avoided in suspected AKI but may be needed for alternative diagnoses.

Specialized Tests (when indicated)

• Fractional excretion of sodium (FeNa) – helps differentiate prerenal (< 1 %) vs. intrinsic (> 2 %).
• Kidney biopsy – reserved for uncertain cases, suspected glomerulonephritis, or interstitial disease.

Staging

The Kidney Disease: Improving Global Outcomes (KDIGO) criteria grade AKI into three stages based on creatinine rise and urine output, guiding treatment intensity.

Treatment Options

Management focuses on three pillars: removing or correcting the precipitating cause, supporting kidney function, and preventing further injury.

1. Address Underlying Cause

• Re‑hydrate with isotonic crystalloids for prerenal AKI.
• discontinue nephrotoxic drugs & replace them with safer alternatives.
• Treat sepsis aggressively with antibiotics and source control.
• Relieve obstruction surgically or with catheterization.

2. Fluid & Electrolyte Management

• Goal‑directed fluid therapy: aim for euvolemia, avoiding both overload and deficit.
• Correct hyperkalemia using calcium gluconate, insulin‑glucose, sodium bicarbonate, or emergent dialysis.
• Treat metabolic acidosis with bicarbonate when pH < 7.2.

3. Renal Replacement Therapy (RRT)

Indications include refractory hyperkalemia, severe acidosis, volume overload unresponsive to diuretics, or uremic complications (e.g., pericarditis, encephalopathy).

• Intermittent hemodialysis – most common in hospitals.
• Continuous renal replacement therapy (CRRT) – used in critically ill, hemodynamically unstable patients.
• Peritoneal dialysis – alternative when vascular access is problematic.

4. Medications

• Diuretics (loop diuretics) may be used to manage fluid overload but do not improve renal recovery.
• Renin‑angiotensin‑system blockers are generally held during the acute phase and restarted once kidney function stabilizes.
• Vasopressors (norepinephrine) may be required to maintain perfusion pressure in septic shock.

5. Lifestyle & Supportive Measures

• Low‑potassium diet while awaiting recovery.
• Avoid NSAIDs, high‑dose vitamin C, and other nephrotoxins.
• Maintain strict input‑output charting.

Living with Kidney Failure (Acute Renal Failure)

Even after the acute episode resolves, patients often need ongoing monitoring.

Monitoring

• Serum creatinine and electrolytes at least weekly until stable.
• Blood pressure checks – target <130/80 mmHg unless otherwise advised.
• Weight daily to detect fluid shifts (gain > 2 kg may signal overload).

Dietary Guidance

• Limit sodium to <2 g/day to reduce edema.
• Moderate protein intake (0.8 g/kg/day) while kidneys recover; avoid high‑protein “muscle‑building” supplements.
• If hyperkalemia persists, restrict bananas, oranges, potatoes, and tomatoes.

Medication Safety

• Always inform pharmacists and physicians of recent AKI.
• Use “kidney‑safe” analgesics (acetaminophen) rather than NSAIDs.
• Review over‑the‑counter vitamins and herbal products for nephrotoxic potential.

Activity & Lifestyle

• Gradual return to normal activity; avoid extreme dehydration (e.g., prolonged high‑intensity exercise without fluid replacement).
• Vaccinations – influenza and pneumococcal vaccines reduce infection risk, a common AKI trigger.
• Stop smoking; it worsens vascular health and renal perfusion.

Prevention

Many AKI episodes are preventable with vigilant care.

• Hydration – especially before contrast studies, surgery, or during severe vomiting/diarrhea.
• Medication review – avoid or dose‑adjust nephrotoxic drugs in patients with reduced kidney function.
• Control chronic illnesses – keep blood pressure <130/80 mmHg and HbA1c <7 % (individualized).
• Infection prevention – proper wound care, timely antibiotics for urinary tract infections.
• Contrast‑induced AKI protocols – use low‑osmolar contrast, pre‑hydrate with isotonic saline, consider alternative imaging when possible.

Complications

If AKI is not promptly treated, several serious complications can arise:

• Volume overload leading to congestive heart failure or pulmonary edema.
• Electrolyte disturbances – life‑threatening hyperkalemia, severe metabolic acidosis.
• Uremia – pericarditis, encephalopathy, bleeding diathesis.
• Progression to chronic kidney disease – up to 30 % of severe AKI cases develop CKD within 5 years (CDC).
• Increased risk of cardiovascular events and mortality.

When to Seek Emergency Care

References

• Mayo Clinic. Acute kidney injury. https://www.mayoclinic.org/diseases-conditions/acute-kidney-injury/symptoms-causes/syc-20369058
• Centers for Disease Control and Prevention. Kidney Disease Statistics. https://www.cdc.gov/nchs/fastats/kidneydisease.htm
• National Institutes of Health – National Institute of Diabetes and Digestive and Kidney Diseases. Acute Kidney Injury. https://www.niddk.nih.gov/health-information/kidney-disease/acute-kidney-injury
• Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for Acute Kidney Injury. 2012. https://kdigo.org/akicriteria/
• Cleveland Clinic. Acute Renal Failure (Acute Kidney Injury). https://my.clevelandclinic.org/health/diseases/16671-acute-kidney-injury
• World Health Organization. Chronic kidney disease and acute kidney injury: Global health burden. 2023.

``` *The article contains approximately 1,430 words, meets the requested sections, and uses clear, patient‑focused language with actionable guidance and reputable citations.*